33:
301:
280:
In July 2016, Anderson returned to the U.S. to lead North
American Operations at Roche's subsidiary, Genentech. From 2017 to 2018, he was the CEO of Genentech. While at Genentech, he developed its immunology and ophthalmology divisions, managed the sales of
660:
422:
316:
From 2019 to 2022, Anderson was CEO of Roche's pharmaceuticals division. During
Anderson's tenure at Roche, he facilitated the company's transition from a focus on
360:
522:
443:
381:
640:
477:
186:
79:
645:
609:
32:
567:
548:
402:
293:, and directed Roche's late-stage portfolio committee for nearly four years, where he was responsible for determining late-stage
386:
174:
75:
320:. He headed the development and launch of new drugs to compensate for the decrease in revenues from oncology drugs whose
588:
655:
549:"Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs"
205:
527:
501:
270:
135:
635:
650:
665:
170:
166:
38:
614:
448:
407:
343:, and he is the second CEO in Bayer's history to be hired from outside the company after Dekkers.
336:
131:
89:
178:
209:
93:
201:
335:. The selection process had begun in mid-2022 and by April 2023, he became a member of the
506:
427:
244:
478:"Can new Genentech CEO Bill Anderson keep and build on the biotech's 'casual intensity'?"
340:
332:
294:
240:
629:
263:
365:
300:
269:
In 2013, Anderson moved to
Switzerland to be head of global product strategy and
213:
162:
63:
259:
182:
305:
255:
248:
221:
146:
111:
328:
317:
139:
593:
286:
282:
236:
225:
217:
444:"Bayer's New American CEO to Study Wounded Pharma Giant Before Acting"
321:
290:
232:
610:"Bayer Hires Former Roche Executive to Succeed CEO Werner Baumann"
309:
299:
274:
150:
107:
103:
589:"Bayer picks outsider Anderson as CEO after investor pressure"
258:, where he eventually became the senior vice president of the
403:"Roche Taps Genentech Chief to Lead Pharmaceuticals Division"
339:
of Bayer AG. He is the second foreigner to lead Bayer after
361:"Wechsel an der Spitze – Bill Anderson übernimmt das Ruder"
423:"Bayer-Chef Baumann tritt ab, Bill Anderson übernimmt"
608:
Boston, William; Thomas, Patrick (February 8, 2023).
327:
On June 1, 2023, Anderson assumed the role of CEO of
568:"Former Genentech CEO to leave parent company Roche"
239:, the U.S., and the U.K., holding positions such as
382:"Roche-Manager Bill Anderson wird neuer Bayer-Chef"
117:
99:
85:
71:
46:
23:
523:"Der Kalifornier Bill Anderson soll Bayer führen"
153:'s Pharmaceuticals Division from 2019 to 2022.
145:Prior to his current role, Anderson was CEO of
583:
581:
8:
661:Massachusetts Institute of Technology alumni
495:
493:
491:
192:Anderson is married and has three children.
471:
469:
467:
465:
463:
461:
459:
31:
20:
200:Anderson started his career in 1989 as a
161:Anderson was born on August 23, 1966, in
149:from 2017 to 2018, and later CEO of the
352:
273:of the pharmaceuticals division at the
16:American business executive (born 1966)
542:
540:
538:
500:Höning, Von Antje (February 8, 2023).
231:From 1997 to 2006, Anderson worked at
130:(born August 23, 1966) is an American
521:Käding, Von Thomas (August 2, 2023).
187:Massachusetts Institute of Technology
80:Massachusetts Institute of Technology
7:
401:Roland, Denise (December 10, 2018).
220:. From 1995 to 1997, he worked as a
380:Jansen, Jonas (February 8, 2023).
235:in multiple countries, including,
185:and chemical engineering from the
14:
442:Boston, William (April 5, 2023).
566:Leuty, Ron (December 12, 2022).
502:"Ein Amerikaner wird Bayer-Chef"
547:Leuty, Ron (December 9, 2018).
482:San Francisco Business Journal
387:Frankfurter Allgemeine Zeitung
1:
175:University of Texas at Austin
76:University of Texas at Austin
641:American business executives
572:San Francisco Business Times
553:San Francisco Business Times
266:and bio-oncology divisions.
646:American chemical engineers
476:Leuty, Ron (June 8, 2017).
682:
254:In 2006, Anderson joined
30:
206:research and development
157:Early life and education
271:chief marketing officer
136:chief executive officer
313:
528:Kölner Stadt-Anzeiger
303:
251:business at Biogen.
171:chemical engineering
39:World Economic Forum
615:Wall Street Journal
597:. February 9, 2023.
449:Wall Street Journal
431:. February 8, 2023.
408:Wall Street Journal
337:Board of Management
314:
132:business executive
90:Business executive
210:Ethyl Corporation
167:bachelor's degree
142:since June 2023.
134:who has been the
125:
124:
94:Chemical engineer
673:
656:Genentech people
620:
619:
605:
599:
598:
585:
576:
575:
563:
557:
556:
544:
533:
532:
518:
512:
511:
497:
486:
485:
473:
454:
453:
439:
433:
432:
419:
413:
412:
398:
392:
391:
377:
371:
370:
357:
275:Roche Holding AG
202:process engineer
128:William Anderson
60:
56:
54:
35:
21:
681:
680:
676:
675:
674:
672:
671:
670:
626:
625:
624:
623:
607:
606:
602:
587:
586:
579:
565:
564:
560:
546:
545:
536:
520:
519:
515:
507:Rheinische Post
499:
498:
489:
475:
474:
457:
441:
440:
436:
428:Manager Magazin
421:
420:
416:
400:
399:
395:
379:
378:
374:
369:. June 1, 2023.
359:
358:
354:
349:
304:Anderson visit
245:general manager
198:
179:master's degree
159:
110:
106:
92:
78:
72:Alma mater
67:
61:
58:
57:August 23, 1966
52:
50:
42:
26:
17:
12:
11:
5:
679:
677:
669:
668:
663:
658:
653:
648:
643:
638:
628:
627:
622:
621:
600:
577:
558:
534:
513:
487:
455:
434:
414:
393:
372:
351:
350:
348:
345:
341:Marijn Dekkers
333:Werner Baumann
297:advancements.
295:clinical trial
241:vice president
197:
194:
158:
155:
123:
122:
119:
115:
114:
101:
97:
96:
87:
83:
82:
73:
69:
68:
62:
48:
44:
43:
36:
28:
27:
24:
15:
13:
10:
9:
6:
4:
3:
2:
678:
667:
664:
662:
659:
657:
654:
652:
649:
647:
644:
642:
639:
637:
636:Living people
634:
633:
631:
617:
616:
611:
604:
601:
596:
595:
590:
584:
582:
578:
573:
569:
562:
559:
554:
550:
543:
541:
539:
535:
530:
529:
524:
517:
514:
509:
508:
503:
496:
494:
492:
488:
483:
479:
472:
470:
468:
466:
464:
462:
460:
456:
451:
450:
445:
438:
435:
430:
429:
424:
418:
415:
410:
409:
404:
397:
394:
389:
388:
383:
376:
373:
368:
367:
362:
356:
353:
346:
344:
342:
338:
334:
331:, succeeding
330:
325:
324:had expired.
323:
319:
311:
307:
302:
298:
296:
292:
288:
284:
278:
276:
272:
267:
265:
264:ophthalmology
261:
257:
252:
250:
246:
242:
238:
234:
229:
227:
223:
219:
215:
211:
207:
203:
195:
193:
190:
188:
184:
180:
176:
172:
168:
165:. He holds a
164:
156:
154:
152:
148:
143:
141:
137:
133:
129:
120:
116:
113:
109:
105:
102:
98:
95:
91:
88:
86:Occupation(s)
84:
81:
77:
74:
70:
65:
59:(age 58)
49:
45:
40:
34:
29:
25:Bill Anderson
22:
19:
651:Bayer people
613:
603:
592:
571:
561:
552:
526:
516:
505:
481:
447:
437:
426:
417:
406:
396:
385:
375:
366:Handelsblatt
364:
355:
326:
315:
279:
268:
253:
230:
224:manager for
199:
191:
160:
144:
127:
126:
18:
666:1966 births
214:Netherlands
163:Ohio, Texas
100:Employer(s)
64:Ohio, Texas
630:Categories
347:References
260:immunology
183:management
53:1966-08-23
306:Chongqing
256:Genentech
249:neurology
222:marketing
173:from the
147:Genentech
138:(CEO) of
112:Genentech
329:Bayer AG
318:oncology
140:Bayer AG
118:Children
594:Reuters
322:patents
287:Raptiva
283:Rituxan
247:of the
237:Ireland
226:Raychem
218:Belgium
212:in the
189:(MIT).
312:, 2024
291:Xolair
289:, and
233:Biogen
196:Career
177:and a
66:, U.S.
310:China
151:Roche
108:Roche
104:Bayer
243:and
216:and
204:for
47:Born
41:2024
208:at
181:in
169:in
37:At
632::
612:.
591:.
580:^
570:.
551:.
537:^
525:.
504:.
490:^
480:.
458:^
446:.
425:.
405:.
384:.
363:.
308:,
285:,
277:.
262:,
228:.
55:)
618:.
574:.
555:.
531:.
510:.
484:.
452:.
411:.
390:.
121:3
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
